Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Feb;71(2):1237-45.
doi: 10.1128/JVI.71.2.1237-1245.1997.

Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain

Affiliations

Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain

J Arroyo et al. J Virol. 1997 Feb.

Abstract

Superantigens have the ability to stimulate subsets of T lymphocytes bearing particular T-cell receptor Vbeta chains. The best-known viral superantigen is Mls, a product of the murine mammary tumor virus (MMTV) sag gene. The MMTV superantigen is not displayed by the virus itself; however, after infection of B lymphocytes, the superantigen is expressed. The resulting immune stimulation is essential for viral transmission. We have analyzed the transcriptional elements which control Mls-1 expression. Here we present evidence that a region at the 3' end of Mtv-7 env, Penv2, controls B-cell-specific expression of sag. Penv2 has elements homologous with promoters of immunoglobulin H chain, the invariant chain, and major histocompatibility complex class II, suggesting a coordinate regulation of expression of these various B-cell-specific genes and indicating a possible eukaryotic origin of MMTV sag. We have determined that both an IgH heptamer element and a Y box are essential for Penv2 promoter activity and that tandem octamer motifs in the U3 region of the 3' MMTV long terminal repeat function as enhancers. We propose that Penv2 controls constitutive Mls expression in B lymphocytes.

PubMed Disclaimer

References

    1. Cell. 1992 May 15;69(4):637-45 - PubMed
    1. J Exp Med. 1992 Jun 1;175(6):1613-21 - PubMed
    1. Science. 1994 Jun 3;264(5164):1415-21 - PubMed
    1. Annu Rev Immunol. 1994;12:259-93 - PubMed
    1. Virology. 1994 Aug 15;203(1):52-62 - PubMed

Publication types

Substances

Associated data

LinkOut - more resources